| H150501A |
Montelukast sodium tablets (JP draft;Dissolution) |
Drugs, Metabolites |
Montelukast sodium |
YMC-Pack Ph |
PH12S05-1003WT |
| H150501B |
Montelukast sodium tablets (USP 40th;Dissolution) |
Drugs, Metabolites |
Montelukast sodium |
YMC-Pack Ph |
PH12S05-1003WT |
| H150501C |
Montelukast sodium oral granules (USP 40th;Dissolution) |
Drugs, Metabolites |
Montelukast sodium |
YMC-Pack Ph |
PH12S05-1003WT |
| F170222A |
Ipriflavone |
Drugs, Metabolites |
Ipriflavone |
YMC-Triart C8 |
TO12S05-1504WT |
| J100407A |
Benzodiazepine derivatives (Triazolam,Etizolam) - LC/MS |
Drugs, Metabolites |
Triazolam
Etizolam |
YMC-Triart C18 |
TA12S05-0502WT |
| O950627B |
Antipsychotic drugs |
Drugs, Metabolites |
Perphenazine
Prochlorperazine maleate
Promazine hydrochloride
Fluphenazine hydrochloride
Trifluoperazine hydrochloride
Ethopropazine hydrochloride (Profenamine hydrochloride)
Chlorpromazine hydrochloride
Thioridazine hydrochloride |
J'sphere ODS-H80 |
JH08S04-L546WT |
| H140204A |
Aripiprazole(USP 36th ; Assay,Impurities) |
Drugs, Metabolites |
Aripiprazole
Aripiprazole related compound F |
YMC-Pack ODS-A |
AA12S03-1046WT |
| S960723A |
Antiepileptics |
Drugs, Metabolites |
Ethosuximide
Primidone
Phenobarbital sodium salt
Phenytoin
Carbamazepine |
YMC-Pack Pro C18 |
AS12S05-1546WT |
| F100621A |
Barbiturates |
Drugs, Metabolites |
Barbital
Phenobarbital
Hexobarbital
Pentobarbital
Secobarbital |
YMC-Triart C18 |
TA12S05-0502WT |
| F100621B |
Barbiturates in human serum |
Drugs, Metabolites |
Barbital
Phenobarbital
Hexobarbital
Pentobarbital
Secobarbital |
YMC-Triart C18 |
TA12S05-0502WT |
| U110611A |
Risperidone (JP 16th;Related substances) |
Drugs, Metabolites |
Risperidone |
YMC-Triart C18 |
TA12S03-1046WT |
| U110604A |
Risperidone Tablets, Fine Granules and Oral Slution (JP 16th;Assay) |
Drugs, Metabolites |
Risperidone |
YMC-Pack ODS-A |
AA30S03-1503WT |
| U110604B |
Risperidone Tablets, Fine Granules and Oral Slution (16th;Related substances) |
Drugs, Metabolites |
Risperidone |
YMC-Pack ODS-A |
AA30S03-1503WT |
| U110604C |
Risperidone Tablets and Fine Granules (JP 16th;Dissolution) |
Drugs, Metabolites |
Risperidone |
YMC-Triart C18 |
TA12S05-1546WT |
| P130703A |
Quetiapine fumarate (JP; Assay,Related substances i) |
Drugs, Metabolites |
Quetiapine fumarate |
YMCbasic |
BA99S05-2546WT |
| P130201A |
Quetiapine fumarate (JP; Related substances ii) |
Drugs, Metabolites |
Quetiapine fumarate |
YMCbasic |
BA99S05-2546WT |
| P130703B |
Quetiapine fumarate tablets (JP; Assay,Related substances) |
Drugs, Metabolites |
Quetiapine fumarate |
YMCbasic |
BA99S05-2546WT |
| P130808D |
Quetiapine fumarate tablets |
Drugs, Metabolites |
Quetiapine fumarate |
YMCbasic |
BA99S05-L546WT |
| P130627B |
Quetiapine fumarate fine granules (JP; Assay) |
Drugs, Metabolites |
Quetiapine fumarate |
YMCbasic |
BA99S05-2546WT |
| R100421E |
Atorvastatin calcium hydrate(JP draft;Related substances) |
Drugs, Metabolites |
Atorvastatin calcium hydrate |
YMC-Pack Pro C18 RS |
RS08S05-2546WT |
